Medicare Enrolled

Dr. Kristy McDonald-Grimm, M.D.

Hematology & Oncology · Douglasville, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4586 TIMBER RIDGE DR, Douglasville, GA 30135
7709420457
In practice since 2007 (19 years)
NPI: 1235356759 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McDonald-Grimm from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McDonald-Grimm? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McDonald-Grimm

Dr. Kristy McDonald-Grimm is a hematology & oncology specialist in Douglasville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. McDonald-Grimm performed 344 Medicare services across 261 unique beneficiaries.

Between the years covered by Open Payments, Dr. McDonald-Grimm received a total of $3,539 from 50 pharmaceutical and/or device companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McDonald-Grimm is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 344 Medicare services $3,539 industry payments

Medicare Practice Summary

Medicare Utilization ↗
344
Medicare services
Bottom 29% in GA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
261
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
 173 $25 $129
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 128 $49 $213
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 31 $78 $314
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
 12 $50 $317
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,539
Total received (2018-2024)
Avg $506/year across 7 years
Top 50% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
172
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,384 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$156 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$850
2023
$423
2022
$268
2021
$588
2020
$253
2019
$480
2018
$677

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$113
Janssen Biotech, Inc.
$108
Daiichi Sankyo Inc.
$76
Eisai Inc.
$58
AstraZeneca Pharmaceuticals LP
$51
Regeneron Healthcare Solutions, Inc.
$51
Merck Sharp & Dohme LLC
$45
Gilead Sciences, Inc.
$45
PFIZER INC.
$42
Mirati Therapeutics, Inc.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$33
Coherus Biosciences Inc.
$23
Genentech USA, Inc.
$23
Pharmacosmos Therapeutics Inc.
$23
BeiGene USA, Inc.
$23
Stemline Therapeutics Inc.
$23
Deciphera Pharmaceuticals Inc.
$19
GlaxoSmithKline, LLC.
$17
PUMA BIOTECHNOLOGY, INC.
$17
Verity Pharmaceuticals Inc.
$14
ARRAY BIOPHARMA INC
$13
Top 3 companies account for 34.8% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$325
Janssen Biotech, Inc.
$263
AstraZeneca Pharmaceuticals LP
$263
TESARO, Inc.
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$159
Merck Sharp & Dohme Corporation
$143
Seagen Inc.
$142
Pharmacyclics LLC, An AbbVie Company
$129
Novartis Pharmaceuticals Corporation
$129
Medtronic USA, Inc.
$122
Daiichi Sankyo Inc.
$113
ABBVIE INC.
$113
PFIZER INC.
$109
Incyte Corporation
$99
Eisai Inc.
$84
Amgen Inc.
$72
Regeneron Healthcare Solutions, Inc.
$70
Merck Sharp & Dohme LLC
$67
Takeda Pharmaceuticals U.S.A., Inc.
$66
GlaxoSmithKline, LLC.
$55
Astellas Pharma US Inc
$46
Gilead Sciences, Inc.
$45
BeiGene USA, Inc.
$45
ARRAY BIOPHARMA INC
$44
Pharmacyclics LLC, an AbbVie Company
$44
Exelixis Inc.
$41
Coherus Biosciences Inc.
$41
Celgene Corporation
$36
TerSera Therapeutics LLC
$35
Seattle Genetics, Inc.
$34
Lilly USA, LLC
$33
Mirati Therapeutics, Inc.
$33
PUMA BIOTECHNOLOGY, INC.
$32
Karyopharm Therapeutics Inc.
$28
Alexion Pharmaceuticals, Inc.
$27
EMD Serono, Inc.
$26
JAZZ PHARMACEUTICALS INC.
$24
Genentech USA, Inc.
$23
Pharmacosmos Therapeutics Inc.
$23
Stemline Therapeutics Inc.
$23
GENZYME CORPORATION
$20
Deciphera Pharmaceuticals Inc.
$19
Midatech Pharma US Inc
$17
Epizyme, Inc.,
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
Array BioPharma Inc.
$16
AMAG Pharmaceuticals, Inc.
$16
Verity Pharmaceuticals Inc.
$14
Taiho Oncology, Inc.
$13
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 24.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · EMEND · EMPLICITI · ENHERTU · ERLEADA · Enhertu · FERAHEME · GILOTRIF · Gelclair · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUPRON DEPOT · LYNPARZA · Lenvima · MEKINIST · NERLYNX · NINLARO · Nplate · OPDIVO · OSTEOCOOL RF ABLATION · Orserdu · PADCEV · PROMACTA · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TUKYSA · Trelstar · ULTOMIRIS · Udenyca · VENCLEXTA · XPOVIO · XTANDI · Xermelo · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Douglasville?
Compare hematology & oncology specialists in the Douglasville area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
118
Per 100K population
80.7
County median income
$80,764
Nearest hospital
WELLSTAR DOUGLAS MEDICAL CENTER
7.8 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McDonald-Grimm is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McDonald-Grimm experienced with office visit, established patient (10-19 min)?
Based on Medicare claims data, Dr. McDonald-Grimm performed 173 office visit, established patient (10-19 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McDonald-Grimm receive payments from pharmaceutical companies?
Yes. Dr. McDonald-Grimm received a total of $3,539 from 50 companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McDonald-Grimm's costs compare to other hematology & oncology specialists in Douglasville?
Dr. McDonald-Grimm's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McDonald-Grimm) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Douglasville
Browse hematology & oncology specialists in Douglasville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →